WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting

FoodTech and AgTech

Open PDF
  • Comprehensive Platform for FoodTech and AgTech Businesses

    As a leading law firm for the technology and life sciences sectors, Wilson Sonsini offers practical advice on the full range of legal issues encountered by companies responsible for the latest innovations in food and agriculture.

The food and agriculture sectors are undergoing transformational changes. New technologies, ranging from alternative proteins to precision agriculture, are changing the food we eat and how food is grown, distributed, and stored. Drawing upon its longstanding experience advising innovative technology and life sciences companies, Wilson Sonsini is well equipped to help FoodTech and AgTech businesses address ongoing and novel legal issues, including in the following areas:

  • Patents: As innovators rapidly develop new methods for creating food and related technologies, a successful intellectual property strategy is essential. Consisting of more than 140 patent attorneys, patent agents, and scientific advisors, our patents and innovations practice offers an extraordinary depth of experience in advising clients on securing, developing, and protecting their IP. Our team features attorneys who have served as in-house legal counsel for major life sciences companies or held senior positions at federal agencies, including the U.S. Patent and Trademark Office and the Patent Trial and Appeal Board. These experiences inform our approach to a full spectrum of IP counseling activities, including patent portfolio management, preparation and prosecution of U.S. and foreign patent applications, freedom-to-operate analyses, and litigation enforcement and defense.
  • Trademark and Copyright : Establishing and maintaining a company’s brand is essential in the food industry, where consumers associate brands with quality and taste. Our trademark and copyright practice is adept at helping innovative companies create and strengthen their brands. Recognized among the leading practitioners in their field by Chambers USA and World Trademark Review, our trademark and copyright attorneys provide a broad range of brand counseling services, including trademark identification and registration; review of advertising copy, labeling and packaging, and marketing campaigns and promotions; advice on compliance with retail and consumer protection law; and brand enforcement.
  • Technology Transactions: FoodTech and AgTech companies enter into a wide variety of complex agreements over the course of their life cycles, including licenses with academic research institutions at inception, supply and distribution agreements when bringing products to market, and joint ventures and strategic transactions to expand their businesses. Our 70-attorney technology transactions team, many members of which hold advanced scientific degrees, has significant experience advising technology and life sciences companies on these kinds of transactions. Their subject matter expertise and business acumen enable them to structure successful agreements and relationships on behalf of our clients.
  • Regulatory: Food and agriculture are subject to a complex array of federal laws and regulations that continue to evolve as new technologies are developed. Our regulatory attorneys are thought leaders in this space, tracking the latest legal developments and crafting practical advice in response. Well versed in both food and drug law and policy overseen by the U.S. Food and Drug Administration and consumer product laws and regulations administered by the Federal Trade Commission and Consumer Product Safety Commission, our team counsels on regulatory compliance strategy, food safety and traceability, labeling and marketing, and product liability matters.
  • Corporate: As the preeminent law firm representing venture-backed technology and life sciences companies, Wilson Sonsini has counseled thousands of enterprises throughout the full corporate life cycle. Our corporate attorneys are experts in every aspect of running a business, including entity formation, corporate governance, equity and debt financing, and M&A, enabling us to serve as strategic advisors at each stage in a company’s growth. Our corporate teams also coordinate with our other practices to ensure seamless interdisciplinary representation for our clients.
Overview

The food and agriculture sectors are undergoing transformational changes. New technologies, ranging from alternative proteins to precision agriculture, are changing the food we eat and how food is grown, distributed, and stored. Drawing upon its longstanding experience advising innovative technology and life sciences companies, Wilson Sonsini is well equipped to help FoodTech and AgTech businesses address ongoing and novel legal issues, including in the following areas:

  • Patents: As innovators rapidly develop new methods for creating food and related technologies, a successful intellectual property strategy is essential. Consisting of more than 140 patent attorneys, patent agents, and scientific advisors, our patents and innovations practice offers an extraordinary depth of experience in advising clients on securing, developing, and protecting their IP. Our team features attorneys who have served as in-house legal counsel for major life sciences companies or held senior positions at federal agencies, including the U.S. Patent and Trademark Office and the Patent Trial and Appeal Board. These experiences inform our approach to a full spectrum of IP counseling activities, including patent portfolio management, preparation and prosecution of U.S. and foreign patent applications, freedom-to-operate analyses, and litigation enforcement and defense.
  • Trademark and Copyright : Establishing and maintaining a company’s brand is essential in the food industry, where consumers associate brands with quality and taste. Our trademark and copyright practice is adept at helping innovative companies create and strengthen their brands. Recognized among the leading practitioners in their field by Chambers USA and World Trademark Review, our trademark and copyright attorneys provide a broad range of brand counseling services, including trademark identification and registration; review of advertising copy, labeling and packaging, and marketing campaigns and promotions; advice on compliance with retail and consumer protection law; and brand enforcement.
  • Technology Transactions: FoodTech and AgTech companies enter into a wide variety of complex agreements over the course of their life cycles, including licenses with academic research institutions at inception, supply and distribution agreements when bringing products to market, and joint ventures and strategic transactions to expand their businesses. Our 70-attorney technology transactions team, many members of which hold advanced scientific degrees, has significant experience advising technology and life sciences companies on these kinds of transactions. Their subject matter expertise and business acumen enable them to structure successful agreements and relationships on behalf of our clients.
  • Regulatory: Food and agriculture are subject to a complex array of federal laws and regulations that continue to evolve as new technologies are developed. Our regulatory attorneys are thought leaders in this space, tracking the latest legal developments and crafting practical advice in response. Well versed in both food and drug law and policy overseen by the U.S. Food and Drug Administration and consumer product laws and regulations administered by the Federal Trade Commission and Consumer Product Safety Commission, our team counsels on regulatory compliance strategy, food safety and traceability, labeling and marketing, and product liability matters.
  • Corporate: As the preeminent law firm representing venture-backed technology and life sciences companies, Wilson Sonsini has counseled thousands of enterprises throughout the full corporate life cycle. Our corporate attorneys are experts in every aspect of running a business, including entity formation, corporate governance, equity and debt financing, and M&A, enabling us to serve as strategic advisors at each stage in a company’s growth. Our corporate teams also coordinate with our other practices to ensure seamless interdisciplinary representation for our clients.
Client Highlights
Wilson Sonsini Advises Hexagon Bio on Multimillion-Dollar Joint Venture with Corteva
On December 16, 2025, Corteva, a global leader in agricultural technology, and Hexagon Bio, a biotechnology company pioneering a new way to discover nature-derived medicine, announced a multimillion-dollar joint venture (JV) to accelerate the development of new crop protection solutions inspired by nature. The JV is the first in the agriculture sector for Hexagon Bio and the first in the pharmaceutical industry for Corteva. Wilson Sonsini Goodrich & Rosati advised Hexagon Bio on the transaction.

The partnership brings together Corteva’s billion-dollar nature-inspired crop protection franchises and bacterial natural product discovery capabilities with Hexagon Bio’s natural-product discovery platform to advance the companies’ respective pipelines across agriculture and human health. Hexagon Bio’s platform combines microbial genetics, artificial intelligence, chemistry, and synthetic biology to identify and characterize novel natural products, uncovering diverse mechanisms not obvious from the chemical structure or conventional techniques and allowing for more efficient molecule discovery.

The Wilson Sonsini team that advised Hexagon Bio on the transaction included Ken Clark, Norm Hovijitra, Aleks Vitomirov, Lance Brady, Christina Poulsen, Adrian Broderick, Sara Pollock, Jacob Morales, Henry Yen, Myra Sutanto Shen, and Rob Sherrill.

For more information, please see the companies’ joint news release.
Client Highlights
Wilson Sonsini Successfully Represents Impossible Foods in First-of-Its-Kind FoodTech Patent Suit
Wilson Sonsini served as lead counsel for Impossible Foods in a patent infringement litigation alleging infringement of seven Impossible Foods patents covering manufacturing processes, ingredients, and finished products relating to plant-based food containing heme and Impossible’s innovative transgenic yeast used to manufacture that heme. Our team successfully represented Impossible Foods in defense of six inter partes review petitions before the Patent Trial and Appeal Board in 2022 and 2023. Wilson Sonsini defeated the defendant’s motion to dismiss and motion to stay the District Court litigation. The matter was closely watched as the first patent infringement case in the burgeoning foodtech industry. With trial approaching, the parties resolved the matter and released a joint statement that said: “This resolution affirms Impossible Foods’ category leadership and the strength of its product portfolio related to heme.”  
Client Highlights
Wilson Sonsini Advises Bonsai Robotics on $15 Million Series A
On January 28, 2025, Bonsai Robotics, a leading developer of physical AI solutions for agriculture applications, announced the successful completion of a $15 million Series A funding round. Bison Ventures led the oversubscribed round with participation from new investor, Cibus Capital, and existing investors Acre Venture Partners, Congruent Ventures, Fall Line Capital, E14 Fund, SNR, and Serra Ventures. Wilson Sonsini Goodrich & Rosati advised Bonsai on the transaction.
 
Bonsai's flagship product, Visionsteer™, provides technology designed to meet grower needs, offering data insights, crop analysis, notifications, job planning, and autonomous vehicle control. The new funding will be used to enhance vision-based autonomous technology and to drive commercialization efforts.
Client Highlights
Firm Advises Meati on $100 Million Series C1 Funding
On May 8, 2024, Meati Foods, a producer of animal-free meats crafted from the company’s unique, whole-food MushroomRoot,™ announced that it has secured $100 million in Series C1 funding, bringing its total raised to $365 million since its founding seven years ago. Wilson Sonsini Goodrich & Rosati advised Meati on the transaction.

The latest round of funding—the largest investment in an alternative protein company since Meati’s own $150 million Series C fundraise in 2022—was led by Grosvenor Food & AgTech, and included returning investors Prelude Ventures, Bond, Revolution Growth, and Congruent. The injection of capital was accompanied by the appointment of Grosvenor Food & AgTech’s Katrin Burt and Prelude Ventures’ Mark Cupta to Meati’s board.

The Wilson Sonsini team advising Meati on the transaction included:

Corporate
Bob O’Connor
Mike Pestana
Viet Nguyen
Michelle Mealer
Janine Swanson
Nathaniel Siegel

Client Highlights
Wilson Sonsini Advises Orbillion on New Funding Round
On March 14, 2024, cultivated meat start-up Orbillion said it has raised fresh capital bringing its cumulative funding to $15 million. The round follows a successful 200-liter production run which the company says validates its predictive modeling platform for "de-risking" the scale-up process for cultivated meat. The round was led by The Venture Collective and co-led by At One Ventures, with participation from YCombinator, Metaplanet, and global food investors including university endowments and strategic investors, and follows a $5 million Seed round announced in 2021.
Client Highlights
Wilson Sonsini Advises Oishii on $134 Million Financing
On February 28, 2024, Oishii, a vertical strawberry farming company, announced a $134 million financing led by Nippon Telegraph and Telephone, with participation from Bloom8, McWin Capital Partners, Mizuho Bank, Mitsubishi Shokuhin Co., Ltd., the Japan Green Investment Corporation for Carbon Neutrality (JICN), and Yaskawa Electric Corporation. Wilson Sonsini Goodrich & Rosati advised Oishii on the transaction. Proceeds from the financing will accelerate Oishii’s expansion plans and support ongoing research and development projects.
View All
Insights
Client Highlights
Wilson Sonsini Advises Hexagon Bio on Multimillion-Dollar Joint Venture with Corteva
On December 16, 2025, Corteva, a global leader in agricultural technology, and Hexagon Bio, a biotechnology company pioneering a new way to discover nature-derived medicine, announced a multimillion-dollar joint venture (JV) to accelerate the development of new crop protection solutions inspired by nature. The JV is the first in the agriculture sector for Hexagon Bio and the first in the pharmaceutical industry for Corteva. Wilson Sonsini Goodrich & Rosati advised Hexagon Bio on the transaction.

The partnership brings together Corteva’s billion-dollar nature-inspired crop protection franchises and bacterial natural product discovery capabilities with Hexagon Bio’s natural-product discovery platform to advance the companies’ respective pipelines across agriculture and human health. Hexagon Bio’s platform combines microbial genetics, artificial intelligence, chemistry, and synthetic biology to identify and characterize novel natural products, uncovering diverse mechanisms not obvious from the chemical structure or conventional techniques and allowing for more efficient molecule discovery.

The Wilson Sonsini team that advised Hexagon Bio on the transaction included Ken Clark, Norm Hovijitra, Aleks Vitomirov, Lance Brady, Christina Poulsen, Adrian Broderick, Sara Pollock, Jacob Morales, Henry Yen, Myra Sutanto Shen, and Rob Sherrill.

For more information, please see the companies’ joint news release.
Client Highlights
Wilson Sonsini Successfully Represents Impossible Foods in First-of-Its-Kind FoodTech Patent Suit
Wilson Sonsini served as lead counsel for Impossible Foods in a patent infringement litigation alleging infringement of seven Impossible Foods patents covering manufacturing processes, ingredients, and finished products relating to plant-based food containing heme and Impossible’s innovative transgenic yeast used to manufacture that heme. Our team successfully represented Impossible Foods in defense of six inter partes review petitions before the Patent Trial and Appeal Board in 2022 and 2023. Wilson Sonsini defeated the defendant’s motion to dismiss and motion to stay the District Court litigation. The matter was closely watched as the first patent infringement case in the burgeoning foodtech industry. With trial approaching, the parties resolved the matter and released a joint statement that said: “This resolution affirms Impossible Foods’ category leadership and the strength of its product portfolio related to heme.”  
Client Highlights
Wilson Sonsini Advises Bonsai Robotics on $15 Million Series A
On January 28, 2025, Bonsai Robotics, a leading developer of physical AI solutions for agriculture applications, announced the successful completion of a $15 million Series A funding round. Bison Ventures led the oversubscribed round with participation from new investor, Cibus Capital, and existing investors Acre Venture Partners, Congruent Ventures, Fall Line Capital, E14 Fund, SNR, and Serra Ventures. Wilson Sonsini Goodrich & Rosati advised Bonsai on the transaction.
 
Bonsai's flagship product, Visionsteer™, provides technology designed to meet grower needs, offering data insights, crop analysis, notifications, job planning, and autonomous vehicle control. The new funding will be used to enhance vision-based autonomous technology and to drive commercialization efforts.
Client Highlights
Firm Advises Meati on $100 Million Series C1 Funding
On May 8, 2024, Meati Foods, a producer of animal-free meats crafted from the company’s unique, whole-food MushroomRoot,™ announced that it has secured $100 million in Series C1 funding, bringing its total raised to $365 million since its founding seven years ago. Wilson Sonsini Goodrich & Rosati advised Meati on the transaction.

The latest round of funding—the largest investment in an alternative protein company since Meati’s own $150 million Series C fundraise in 2022—was led by Grosvenor Food & AgTech, and included returning investors Prelude Ventures, Bond, Revolution Growth, and Congruent. The injection of capital was accompanied by the appointment of Grosvenor Food & AgTech’s Katrin Burt and Prelude Ventures’ Mark Cupta to Meati’s board.

The Wilson Sonsini team advising Meati on the transaction included:

Corporate
Bob O’Connor
Mike Pestana
Viet Nguyen
Michelle Mealer
Janine Swanson
Nathaniel Siegel

Client Highlights
Wilson Sonsini Advises Orbillion on New Funding Round
On March 14, 2024, cultivated meat start-up Orbillion said it has raised fresh capital bringing its cumulative funding to $15 million. The round follows a successful 200-liter production run which the company says validates its predictive modeling platform for "de-risking" the scale-up process for cultivated meat. The round was led by The Venture Collective and co-led by At One Ventures, with participation from YCombinator, Metaplanet, and global food investors including university endowments and strategic investors, and follows a $5 million Seed round announced in 2021.
Client Highlights
Wilson Sonsini Advises Oishii on $134 Million Financing
On February 28, 2024, Oishii, a vertical strawberry farming company, announced a $134 million financing led by Nippon Telegraph and Telephone, with participation from Bloom8, McWin Capital Partners, Mizuho Bank, Mitsubishi Shokuhin Co., Ltd., the Japan Green Investment Corporation for Carbon Neutrality (JICN), and Yaskawa Electric Corporation. Wilson Sonsini Goodrich & Rosati advised Oishii on the transaction. Proceeds from the financing will accelerate Oishii’s expansion plans and support ongoing research and development projects.
View All
Affiliated Programs
San Diego Innovation Council 2025 Innovation Showcase
Wilson Sonsini is pleased to support the 2025 Innovation Showcase, hosted by the San Diego Innovation Council on June 11. This day-long event highlights emerging technologies from leading academic institutions across San Diego and Southern California, featuring presentations and networking opportunities in sectors including software, engineering, clean tech, agriculture, and life sciences. The showcase brings together research-driven innovations, success stories, and early-stage ventures seeking to move from lab to market.
Affiliated Programs
SynBioBeta 2025: The Global Synthetic Biology Conference
Wilson Sonsini is proud to sponsor SynBioBeta 2025: The Global Synthetic Biology Conference, where biology becomes the blueprint and human innovation, the artisan. Attend this event for an unparalleled four-day summit delving into synthetic biology.
Affiliated Programs
London Forum on Global Economic Sanctions
The London Forum on Global Economic Sanctions 2023 program will provide attendees with the most up-to-date developments in economic sanctions from leading financial services organizations as well as global exporters. This is a must-attend for sanctions and financial crime prevention experts.
Affiliated Programs
IAPP Europe Data Protection Congress
Europe’s top gathering of data protection professionals is returning for its 12th year in Brussels. The International Association of Privacy Professionals (IAPP) Europe Data Protection Congress 2023 is the place for delegates to gain insights and working knowledge that will allow you to set a course for the future of your data protection operation. Wilson Sonsini is proud to sponsor this year’s event. To learn more about the conference, and the IAPP, click here.
Speaking Engagements
Connecting MadTech and Money
MadTechMoney brings together ad tech/martech founders and the investment community (private equity, venture capital, corporate development and strategic investors) to discuss key investment trends.
Affiliated Programs
Tech Tour Agritech, Food and Bioeconomy 2023
The Tech Tour Agritech, Food and Bioeconomy 2023 Program promotes innovation and investment into the best technology companies from across Europe and is your chance to connect with VCs, entrepreneurs, industry experts and thought leaders to foster new connections, business and investment.
View All
Events
Affiliated Programs
San Diego Innovation Council 2025 Innovation Showcase
Wilson Sonsini is pleased to support the 2025 Innovation Showcase, hosted by the San Diego Innovation Council on June 11. This day-long event highlights emerging technologies from leading academic institutions across San Diego and Southern California, featuring presentations and networking opportunities in sectors including software, engineering, clean tech, agriculture, and life sciences. The showcase brings together research-driven innovations, success stories, and early-stage ventures seeking to move from lab to market.
Affiliated Programs
SynBioBeta 2025: The Global Synthetic Biology Conference
Wilson Sonsini is proud to sponsor SynBioBeta 2025: The Global Synthetic Biology Conference, where biology becomes the blueprint and human innovation, the artisan. Attend this event for an unparalleled four-day summit delving into synthetic biology.
Affiliated Programs
London Forum on Global Economic Sanctions
The London Forum on Global Economic Sanctions 2023 program will provide attendees with the most up-to-date developments in economic sanctions from leading financial services organizations as well as global exporters. This is a must-attend for sanctions and financial crime prevention experts.
Affiliated Programs
IAPP Europe Data Protection Congress
Europe’s top gathering of data protection professionals is returning for its 12th year in Brussels. The International Association of Privacy Professionals (IAPP) Europe Data Protection Congress 2023 is the place for delegates to gain insights and working knowledge that will allow you to set a course for the future of your data protection operation. Wilson Sonsini is proud to sponsor this year’s event. To learn more about the conference, and the IAPP, click here.
Speaking Engagements
Connecting MadTech and Money
MadTechMoney brings together ad tech/martech founders and the investment community (private equity, venture capital, corporate development and strategic investors) to discuss key investment trends.
Affiliated Programs
Tech Tour Agritech, Food and Bioeconomy 2023
The Tech Tour Agritech, Food and Bioeconomy 2023 Program promotes innovation and investment into the best technology companies from across Europe and is your chance to connect with VCs, entrepreneurs, industry experts and thought leaders to foster new connections, business and investment.
View All
Wendy L. Devine
Partner
San Francisco
Wendy is the firm's patent practice group leader and she represents clients in patent litigation and IP-related matters.
  • Litigation
View Profile
Tina Hanson
Partner
San Francisco
Kristina Hanson is a partner in the San Francisco office of Wilson Sonsini Goodrich & Rosati. Her practice primarily focuses on intellectual property litigation, with an emphasis on pharmaceutical patent matters arising under the Hatch-Waxman Act. She has represented clients in a variety of pharmaceutical matters, from pre-trial strategy counseling through appeals.
  • Litigation
View Profile
Alison G. Johnson
Partner
Alison G. Johnson is a corporate partner at Wilson Sonsini Goodrich & Rosati, where she focuses on the representation of emerging companies at all stages of growth, advising them on venture capital and other financings, mergers and acquisitions, private equity, and corporate governance matters. She also represents venture capital firms and angel investors.
  • Corporate
View Profile
David H. Kramer
Partner
Palo Alto
David represents companies facing challenging disputes involving novel issues of law. 
  • Litigation
View Profile
J. Matthew (Matt) Lyons
Partner
Austin
J. Matthew (Matt) Lyons is a corporate partner in the Austin office of Wilson Sonsini Goodrich & Rosati, where his practice focuses on the representation of companies and their investors in the emerging companies ecosystem. For the past 25 years, he has been a leading attorney in the Texas market, advising public and private companies, venture and private equity funds, and entrepreneurs on new entity formation, venture financings, public and private offerings, mergers, acquisitions and divestitures, and issues related to corporate governance and executive compensation. Matt’s clients include companies in the technology, life sciences, healthcare, retail and CPG, and media and communications industries.
  • Corporate
View Profile
Maya Skubatch
Partner
Palo Alto
Maya focuses on strategic patent counseling for healthcare and other technology-driven companies.
  • Patents and Innovations
View Profile
David F. Wickwire
Partner
Seattle
David focuses on representing fast-growing technology, software, digital media, and clean technology companies, as well as several early-stage venture capital firms.
  • Corporate
View Profile
David M. Hoffmeister
Partner Emeritus
David represents pharmaceutical, biotechnology, medical device, diagnostic, and dietary supplement clients in the life sciences and healthcare industries.
  • Corporate
View Profile
Vern Norviel
Partner Emeritus
Vern has three decades of experience formulating successful strategies for innovative life science companies and helping them develop IP programs.
  • Patents and Innovations
View Profile
Ian Longacre
Senior Counsel
Boston
Ian Longacre is senior counsel in the Boston office of Wilson Sonsini Goodrich & Rosati, where his practice focuses on the representation of pharmaceutical, biotechnology, medical device, diagnostic, and AgTech companies in complex collaboration and partnering transactions. In addition, he helps companies with a broad range of other transactions, including technology and asset acquisition, license, discovery, research, development, manufacture and supply, promotion, marketing, distribution, and services agreements.
  • Technology Transactions
View Profile
View All
People
Wendy L. Devine
Partner
San Francisco
Wendy is the firm's patent practice group leader and she represents clients in patent litigation and IP-related matters.
  • Litigation
View Profile
Tina Hanson
Partner
San Francisco
Kristina Hanson is a partner in the San Francisco office of Wilson Sonsini Goodrich & Rosati. Her practice primarily focuses on intellectual property litigation, with an emphasis on pharmaceutical patent matters arising under the Hatch-Waxman Act. She has represented clients in a variety of pharmaceutical matters, from pre-trial strategy counseling through appeals.
  • Litigation
View Profile
Alison G. Johnson
Partner
Alison G. Johnson is a corporate partner at Wilson Sonsini Goodrich & Rosati, where she focuses on the representation of emerging companies at all stages of growth, advising them on venture capital and other financings, mergers and acquisitions, private equity, and corporate governance matters. She also represents venture capital firms and angel investors.
  • Corporate
View Profile
David H. Kramer
Partner
Palo Alto
David represents companies facing challenging disputes involving novel issues of law. 
  • Litigation
View Profile
J. Matthew (Matt) Lyons
Partner
Austin
J. Matthew (Matt) Lyons is a corporate partner in the Austin office of Wilson Sonsini Goodrich & Rosati, where his practice focuses on the representation of companies and their investors in the emerging companies ecosystem. For the past 25 years, he has been a leading attorney in the Texas market, advising public and private companies, venture and private equity funds, and entrepreneurs on new entity formation, venture financings, public and private offerings, mergers, acquisitions and divestitures, and issues related to corporate governance and executive compensation. Matt’s clients include companies in the technology, life sciences, healthcare, retail and CPG, and media and communications industries.
  • Corporate
View Profile
Maya Skubatch
Partner
Palo Alto
Maya focuses on strategic patent counseling for healthcare and other technology-driven companies.
  • Patents and Innovations
View Profile
David F. Wickwire
Partner
Seattle
David focuses on representing fast-growing technology, software, digital media, and clean technology companies, as well as several early-stage venture capital firms.
  • Corporate
View Profile
David M. Hoffmeister
Partner Emeritus
David represents pharmaceutical, biotechnology, medical device, diagnostic, and dietary supplement clients in the life sciences and healthcare industries.
  • Corporate
View Profile
Vern Norviel
Partner Emeritus
Vern has three decades of experience formulating successful strategies for innovative life science companies and helping them develop IP programs.
  • Patents and Innovations
View Profile
Ian Longacre
Senior Counsel
Boston
Ian Longacre is senior counsel in the Boston office of Wilson Sonsini Goodrich & Rosati, where his practice focuses on the representation of pharmaceutical, biotechnology, medical device, diagnostic, and AgTech companies in complex collaboration and partnering transactions. In addition, he helps companies with a broad range of other transactions, including technology and asset acquisition, license, discovery, research, development, manufacture and supply, promotion, marketing, distribution, and services agreements.
  • Technology Transactions
View Profile
View All
Related Practices
  • Corporate
  • Emerging Companies and Venture Capital
  • Energy and Climate Solutions
  • FDA Regulatory, Healthcare, and Consumer Products
  • Patents and Innovations
  • Technology Transactions
Related Industries
  • Animal Health
  • Biotech
  • Climate and Clean Technologies
  • Consumer Products and Services
  • Life Sciences
Recent Insights
Client Highlights
Wilson Sonsini Advises Hexagon Bio on Multimillion-Dollar Joint Venture with Corteva
On December 16, 2025, Corteva, a global leader in agricultural technology, and Hexagon Bio, a biotechnology company pioneering a new way to discover nature-derived medicine, announced a multimillion-dollar joint venture (JV) to accelerate the development of new crop protection solutions inspired by nature. The JV is the first in the agriculture sector for Hexagon Bio and the first in the pharmaceutical industry for Corteva. Wilson Sonsini Goodrich & Rosati advised Hexagon Bio on the transaction.

The partnership brings together Corteva’s billion-dollar nature-inspired crop protection franchises and bacterial natural product discovery capabilities with Hexagon Bio’s natural-product discovery platform to advance the companies’ respective pipelines across agriculture and human health. Hexagon Bio’s platform combines microbial genetics, artificial intelligence, chemistry, and synthetic biology to identify and characterize novel natural products, uncovering diverse mechanisms not obvious from the chemical structure or conventional techniques and allowing for more efficient molecule discovery.

The Wilson Sonsini team that advised Hexagon Bio on the transaction included Ken Clark, Norm Hovijitra, Aleks Vitomirov, Lance Brady, Christina Poulsen, Adrian Broderick, Sara Pollock, Jacob Morales, Henry Yen, Myra Sutanto Shen, and Rob Sherrill.

For more information, please see the companies’ joint news release.
Learn More
Client Highlights
Wilson Sonsini Successfully Represents Impossible Foods in First-of-Its-Kind FoodTech Patent Suit
Wilson Sonsini served as lead counsel for Impossible Foods in a patent infringement litigation alleging infringement of seven Impossible Foods patents covering manufacturing processes, ingredients, and finished products relating to plant-based food containing heme and Impossible’s innovative transgenic yeast used to manufacture that heme. Our team successfully represented Impossible Foods in defense of six inter partes review petitions before the Patent Trial and Appeal Board in 2022 and 2023. Wilson Sonsini defeated the defendant’s motion to dismiss and motion to stay the District Court litigation. The matter was closely watched as the first patent infringement case in the burgeoning foodtech industry. With trial approaching, the parties resolved the matter and released a joint statement that said: “This resolution affirms Impossible Foods’ category leadership and the strength of its product portfolio related to heme.”  
Learn More
View All
Recent Events
Affiliated Programs
San Diego Innovation Council 2025 Innovation Showcase
Wilson Sonsini is pleased to support the 2025 Innovation Showcase, hosted by the San Diego Innovation Council on June 11. This day-long event highlights emerging technologies from leading academic institutions across San Diego and Southern California, featuring presentations and networking opportunities in sectors including software, engineering, clean tech, agriculture, and life sciences. The showcase brings together research-driven innovations, success stories, and early-stage ventures seeking to move from lab to market.
Learn More
Affiliated Programs
SynBioBeta 2025: The Global Synthetic Biology Conference
Wilson Sonsini is proud to sponsor SynBioBeta 2025: The Global Synthetic Biology Conference, where biology becomes the blueprint and human innovation, the artisan. Attend this event for an unparalleled four-day summit delving into synthetic biology.
Learn More
View All
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.